P-281: Adjusted comparison of teclistamab versus physician’s choice of therapy in the long-term follow-up of daratumumab trials in patients with triple-class exposed relapsed or refractory multiple myeloma
Title:
P-281: Adjusted comparison of teclistamab versus physician’s choice of therapy in the long-term follow-up of daratumumab trials in patients with triple-class exposed relapsed or refractory multiple myeloma
Author:
Mateos, María-Victoria Chari, Ajai Usmani, Saad Goldschmidt, Hartmut Weisel, Katja Qi, Keqin Londhe, Anil Nair, Sandhya Lin, Xiwu Pei, Lixia Ammann, Eric Kobos, Rachel Smit, Jennifer Parekh, Trilok Marshall, Alexander Slavcev, Mary Moreau, Philippe